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Abstract
Substandard, spurious, falsely labeled, falsifi ed, 
and counterfeit (SSFFC) medications are a major 
concern in countries around the world, especially 
in the developing world. Forged and substandard 
medications pose major threats to the well-being 
and economic status of citizens in developing 
countries. This research focuses on designing an 
educational module and laboratory exercise that 
will teach students how to detect SSFFC medi-
cations with a universal method using high-per-
formance liquid chromatography (HPLC). This 
research is also focused on the implementation of 
the module at the Kilimanjaro School of Phar-
macy (KSP) located in Tanzania. Acetaminophen 
tablets from four countries were purchased in 
Tanzania and tested at Purdue University and 
KSP yielding an adequate sample of HPLC 
data to establish the purity of the drug product. 
Utilizing the approach developed here, additional 
medications can be analyzed to combat con-
cerns about SSFFC medications in Tanzania and 
throughout the developing world. Furthermore, 
we describe the implementation of this method in 
Tanzania at KSP.  
Maize, H., Mavity, M., McCord, J., Schramm, S., 
Stepanovic, M., & Wintczak, D. (2017). Method 
to improve drug safety in Africa: A pharma-
ceutical learning module. Journal of Purdue 
Undergraduate Research, 7, 8–17. https://doi.
org/10.5703/1288284316392
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INTRODUCTION
Substandard, spurious, falsely labeled, falsifi ed, 
and counterfeit (SSFFC) medications are a global 
problem with their prevalence being more apparent 
in countries in the developing world including 
Tanzania. SSFFC drugs pose major problems to the 
individuals who take them including the emergence 
of antimicrobial resistance and increased morbidity 
and mortality (Mwambete, 2014). In addition, 
overuse and misuse of antibiotic drugs is frequently 
reported (Viberg, Kalala, Mujinja, Tomson, & 
Lundborg, 2010). It is common for SSFFC drugs 
to be sold by vendors in markets throughout 
Tanzania. These drugs mimic the size, shape, and 
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packaging of genuine drugs without offering the 
desired efficacious effect. These SSFFC drugs waste 
resources, put individuals at risk of continued illness, 
and discourage individuals from purchasing genuine 
and life-saving drugs. 
 
In 2008, the World Health Organization (WHO), 
United Nations Educational, Scientific and Cultur-
al Organization (UNESCO), and the International 
Pharmaceutical Federation (FIP) collaborated to 
create a Pharmacy Education Taskforce (PFT) in 
order to develop a Pharmacy Education Action Plan 
for 2008–2010. As of 2008, the WHO estimated 
that there was a shortage of more than four million 
healthcare workers worldwide; it was reported, as 
well, that 57 countries fell under the WHO threshold 
of 2.5 health care professionals per 1,000 population. 
These shortages can hinder other health programs 
and can form a barrier when trying to reach the 
Millennium Development Goals being set to im-
prove the quality of life for people around the globe 
(Anderson et al., 2008). Pharmacists are usually not 
the first healthcare professionals considered when 
looking at countries with insufficient health care 
systems, however, pharmacists are a vital component 
of the health-care system. For many underprivileged 
communities, the pharmacist is the most common 
and, in some cases, the sole provider of healthcare for 
several reasons, including proximity, cost associated 
with visiting a doctor or physician, and lack of avail-
ability of other options (Anderson et al., 2008). In 
most nonurban communities, private drugstores that 
are licensed to sell over-the-counter drugs are the 
prominent source of medications for poorer citizens; 
the Tanzanian Ministry of Health acknowledges the 
importance of private drugstores throughout Tanza-
nia, as well, in providing health care to the country’s 
citizens (Viberg et al., 2010). In addition, in Africa 
over 75% of antibiotics are incorrectly prescribed 
to patients (Mwambete, 2014, p. 98). This is due to 
the incorrect drug type being prescribed and the 
frequency of SSFFC drugs in health-care systems in 
Africa (Mwambete, 2014). Having a lack of educated 
pharmacists in Tanzania is an issue that needs to be 
addressed in order to help provide better health care 
to the people of Tanzania. To address this issue, there 
needs to be a system in place to educate more phar-
macists for the workforce. 
 
This paper describes an educational module designed 
to educate students about SSFFC medicines and a 
laboratory exercise that illustrates the strategy for 
detecting SSFFC medicines. Indirectly, this module 
and laboratory exercise illustrates how drug quality 
can be ensured using laboratory assays and methods. 
Additionally, this paper describes a universal method 
for distinguishing between SSFFC and non-SSFFC 
drugs. Additionally, we describe implementation of 
this method in Tanzania at the Kilimanjaro School of 
Pharmacy (KSP). Strategies to increase pharmaceuti-
cal education and expertise in Tanzania and ways of 
detecting the sale of SSFFC drugs in the Kilimanjaro 
region of Tanzania also are discussed. Alternatively, 
this module also could be used outside the developing 
world to illustrate the principles of high-performance 
liquid chromatography (HPLC) and drug quality.
 
Since the Pharmacy Education Action Plan described 
that a “one size fits all” educational model is not 
a practical solution for providing pharmaceutical 
education to all areas of the world and because some 
individuals lack sufficient knowledge in certain 
pharmaceutical practices (Anderson et al., 2008), the 
Global Development Team of Purdue University de-
veloped a local pharmaceutical education model that 
will help train the future pharmacists of Tanzania. 
This module contains an initial video on the problems 
of counterfeiting, a video on the utilization of HPLC to 
detect SSFFC medications, and a laboratory module 
utilizing the universal method to detect SSFFC drugs. 
We believe these modules can be further used in the 
United States to educate pharmacists.
METHODS
An Agilent 1100 HPLC equipped with ChemStation 
software was used for the study. Standard HPLC 
solvents were used. In Tanzania, HPLC solvents 
can be obtained from Kenya and other major HPLC 
suppliers. Proper laboratory personal protective 
equipment (PPE) is required, including gloves,  
long pants, closed toed shoes, safety glasses, and 
lab coats. All glassware is cleaned and prewashed 
with methanol.
 
An Agilent Zorbax 4.6 cm C-18 column with  
5-micron particle size is used. The column is  
pre-equilibrated with 50:50 ACN (Acetonitrile):  
H2O (water). 
 
Agilent ChemStation software is used to analyze the 
data. The Data Analysis tab allows easy determina-
tion of peak areas and percentages.
 
Typically, an average of three injections are used 
for determination of percentages. In some cases, 
three separate preparations with three injections 
each are used.
 
As an example, for acetaminophen, the contents of 
ten 500 mg tablets are added to a 200 milliliter (mL) 
volumetric flask and diluted with 200 mL of buffer. 
11
phosphate. For acetaminophen, only methanol and 
water were utilized.
Preparation of Drug Tablet Assay Samples
Tablet extraction was completed for Equate brand 
500 mg acetaminophen tablets from Tanzania. This 
was prepared by crushing ten Equate brand 500 mg 
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Parameters Values
Column Agilent Zorbax SB-C18 4.6mmx250mm 1
Pump A Methanol
Pump B Water
Mobile Phase 50 mL Methanol + 150 mL Water
Gradient
Time (min)      A%          B%  
 0           25           75
 10           25           75
Injection Volume 10 µL
Temperature 25°C
UV Detector 243 nm (Reference 360 nm & 100 nm)
USP Compound 0.01 mg/ml of acetamino-phen in mobile phase
Extraction Procedure 
and Drug Preparation
•100mg of acetaminophen 
in a 200mL volumetric 
flask
• Add 100mL mobile 
phase, stir, dilute to 
volume (~200 mL mobile 
phase)
• Using a funnel and an 
empty flask, pass solu-
tion through filter paper
• Extract 1.5mL of this 
solution into an HPLC 
test tube
Stability Information
The prepared drug buffer 
has been shown to remain 
stable for up to 2 weeks 
under refrigeration
Acceptance Criteria No peaks on the blank
Acceptance Results >99% peak area within 5 to 5.1 minutes
Average Retention 
Time 5.05 minutes
Average Area % 99.95%
1 USP suggests 3.9mm x 30 cm, L1 packing
Table 1. HPLC method for acetaminophen.
The solution is stirred, filtered, and tested in a  
3:1 methanol to water gradient over 10 minutes.  
The wavelength of the detector is set a 243 nanome-
ters (nm). 
 
An autonomous laboratory model using acetamino-
phen as the testing material, below, can provide an 
understanding of the applicability of this process 
to both the analysis of a medication for SSFFC 
properties and the use of HPLC units by students to 
understand the quality of a drug.
 
The procedure outlined below constitutes our current 
universal method. Furthermore, the universal method 
was applied to Amoxicillin, Quinine, Coartem, 
Hydrochlorothiazide and Mefloquine tablets. Our 
preliminary studies suggest it can be used for these 
drug products. Initial studies of Ciprofloxacin, 
Dexamethasone, Metformin, Carvedilol, Amitripty-
line and Haloperidol based on overlap between the 
Walmart $4 list and the WHO Essential Medicines 
list have been conducted.
EDUCATIONAL MODULE 1: ACETAMINOPHEN
Purpose
The United States Pharmacopeia (USP) is responsible 
for setting and publishing the standards for testing the 
quality of all medications. The USP contains verified 
methods for analyzing drugs, including the quantified 
best HPLC procedures for Acetaminophen. 
 
In this lab, we will separate and quantify the amount 
of acetaminophen in various products. Parameters 
set forth in Table 1 will be utilized. 
  
We also utilized acetaminophen USP-level standard 
from Purdue University Industrial and Physical 
Pharmacy Department and Methanol purchased from 
Sigma-Aldrich. Fresh ultrapure water was obtained 
from a Milli-Q Integral system. 
Preparation of Standard Solutions
First, 100 mg of acetaminophen was placed in a 200 
mL volumetric flask. Then, 100 mL of mobile phase 
was added to the flask and it was stirred and diluted 
to a volume of approximately 200 mL with mobile 
phase. Using a funnel and an empty flask, the solu-
tion was passed through filter paper. Finally, 1.5 mL 
of solution was placed into an HPLC vial. 
Solvents
The universal method makes use of four solvents: 
water, methanol, acetonitrile, and 0.5M potassium 
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three separate trials. Tablet samples were filtered 
for accurate results. If the sample was not filtered, it 
may appear similar to Figure 3, with two wide peaks 
between 4.5 and 5.5 minutes.  
Once the universal method for acetaminophen was 
established, further studies were conducted on 
amoxicillin tablets using the HPLC.
adding 100 mg of the crushed powder to a 200 mL 
volumetric flask, and adding 100 mL of mobile 
phase to the flask. After approximately 10 minutes 
of mixing, the solution is diluted to 200 mL with 
mobile phase and mixed for approximately another 
5 minutes. Using a funnel and an empty flask, the 
solution is passed through filter paper. Finally, 1.5 
mL of solution is placed in an HPLC vial. 
Measurements
Each HPLC trial, for all samples, consisted of a 
blank run and 3 sample runs. A reference standard 
was prepared and tested in three separate trials. The 
average retention time of the reference standard was 
5.04 minutes with an average peak area of 99.95%. A 
sample result is shown in Figure 1.
Three separate extractions of Equate brand 
acetaminophen tablets were prepared and tested in 
three separate trials each, for a total of nine trials. 
The average results of these extractions were used to 
set acceptance limits for this method as a retention 
time of 5.05 minutes and a peak area percent of 
99.95% with a standard deviation of 0.011 and 0.053, 
respectively. Limits to the acceptance criteria were 
set based on verification that extraction test results 
were significantly tighter than these values. A sample 
result for the extractions, indicative of expected 
results for this method is shown in Figure 2. 
 
One unfiltered extraction of Equate brand 
acetaminophen tablets was prepared and tested in 
Figure 1. Sample chromatogram for HPLC         
acetaminophen reference standard. 
Figure 2. Sample chromatogram for HPLC  
acetaminophen tablet extraction is indicative  
of expected results for this procedure. 
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and used as a comparison. The reference standard’s  
average retention time for amoxicillin was 5.76  
minutes with an average peak area of 94.12%. 
 
In total, nine trials of amoxicillin capsules were 
assessed. It was found that the accepted limits for 
the amoxicillin method were set at a retention time 
of 5.76 and a peak area of 94.12% with a standard 
deviation of 0.071 and 1.47, respectively. 
DISCUSSION
HPLC analysis was utilized as opposed to other 
methods in this project for several reasons. HPLC 
excels at the analysis of small, organic molecules 
which is a feature shared by every drug analyzed 
or every drug intended to be analyzed. For this 
reason, HPLC has also been widely utilized by the 
pharmaceutical industry and is the main method 
used to analyze drugs for purity. Additionally, 
HPLC is highly adaptable. Many different variables 
can be manipulated on an HPLC, including the size 
and type of column, polarity of the solvents, flow 
rate, wavelength of excitation, injection size, and 
several others. This makes HPLC very versatile, 
able to be manipulated to analyze an endless 
numbers of drugs, and perfect for the development 
of a universal method. 
 
Separations using high-pressure liquid 
chromatography (HPLC) depend upon the basic 
processes of adsorption, partition, ion exchange, 
and molecular exclusion, as previously discussed. 
The advantages of using HPLC as compared to 
classical chromatographic methods are greater 
speed, precision, accuracy, and ease of operation. 
The column materials used in HPLC are of unique 
structure and provide the basis for separations.
 
A wide variety of aqueous and nonaqueous solvents 
may be used as the mobile phase. Solvents must be 
degassed before they can be used or the detector 
will adsorb bubbles and erroneous readings will be 
obtained. The mobile phase is generally pumped 
through the column under pressure. Most commer-
cial instruments are capable of providing pressures 
up to 7000 psi.
 
Ultraviolet (UV) absorbance and refractive index 
detectors are most frequently used in HPLC. UV 
detectors are available with fixed and variable 
wavelengths. This type of detector monitors the 
column effluent continuously as it passes through the 
microcell. Since the signal is measured in absorbance 
units and recorded versus time, a differential plot 
(peak) is obtained on the recorder.
EDUCATIONAL MODULE 2: AMOXICILLIN
Purpose
Established United States Pharmacopeia (USP) meth-
ods were referenced when shaping the proper HPLC 
method for amoxicillin capsules. These reference 
methods are governed by the USP who is responsible 
for the determining and publication of analysis on the 
quality of all medications. 
 
Amoxicillin will be isolated and measured, and 
results will be compared to products of the generic 
tablet of the same makeup in this laboratory module. 
 
Supplies for the module were obtained from Pur-
due University Industrial and Physical Pharmacy 
Department (amoxicillin USP-level), Sigma-Aldrich 
(methanol), and Milli-Q Integral System (fresh ultra-
pure water).
Preparation of Standards
First, 250 mg of amoxicillin was measured and 
placed in a 100 mL volumetric flask. The flask with 
its contents was then diluted with 100 mL of potassi
um phosphate buffer at pH 5 (Pump A). This mix-
ture was then stirred for approximately 30 minutes. 
Utilizing a funnel and an empty flask, the contents 
of the volumetric flask were strained through filter 
paper, and 1.5 mL of this sieved solution was placed 
in an HPLC vial for analysis. 
Solvents
Four solvents are essential in the universal method: 
water, methanol, acetonitrile, and 0.5 M potassium 
phosphate. For amoxicillin, only methanol and potas-
sium phosphate were utilized.
Preparation of Drug Tablet Assay Samples 
 
A single capsule of amoxicillin is fragmented, 
and the contents are then placed into a 100 mL 
volumetric flask. Amoxicillin was diluted with  
100 mL of buffer from Pump A. This blend is 
mixed for approximately 30 minutes. Utilizing 
a funnel and an empty flask, the contents of the 
volumetric flask were strained through filter paper 
and 1.5 mL of this sifted solution was placed in an 
HPLC vial for analysis. 
Measurements
For all samples and their HPLC trials, a blank run 
and three sample runs were implemented. In three 
separate trials, a reference standard was prepared  
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These drugs, just like any other set of drugs, vary 
greatly in terms of solubility. Some are more polar 
and, therefore, readily soluble in our polar solvents, 
while others are more nonpolar. Thus, these different 
drugs have different solubility and different rates of 
dissolution. That being said, the solubility of these 
drugs is similar enough that we have been able to 
both dissolve them all in the same solvents and uti-
lize the same column for analysis.
 
Upon starting this project, one of the major 
challenges was proving that the results were 
consistent with what was, in fact, correct. To do this, 
USP standards were purchased, and the results were 
compared to those displayed from the USP analysis 
in the monograph for each drug. If this method 
produced results comparable to the USP HPLC 
results, it was concluded that method was suitable 
for that specific drug.
 
The thought process for choosing the original drugs 
has been previously discussed. This process directly 
influenced the process for selecting the solvents. 
The only solvents utilized in the acetaminophen 
method were readily accessible and widely used. 
After selecting other drugs to test and researching 
methods by which to analyze them, it was found that 
four solvents were common to HPLC methods per 
The USP contains a general chapter, USP<621>, 
on chromatography. This chapter describes 
approaches to separations and analysis of drugs 
using chromatographic methods. It also describes 
quantitative analysis of drugs using both external 
standard and internal standard. The USP sells 
standards for this purpose. The availability of 
standards makes this study much more feasible.
 
When first beginning the project, many important 
decisions, including which drugs to test and how to 
adapt our methods for universal drug applicability, 
had to be made. The initial criterion was choos-
ing drugs that were the low-hanging fruit: cheap, 
readily accessible, widely utilized, and simple to 
test. Amoxicillin was an all but obvious first choice 
based on these criteria. After this selection, drugs 
that seemed like they were widely utilized or might 
be readily utilized throughout Africa were chosen. 
These criteria led to hydrochlorothiazide, quinine, 
mefloquine, lumefantrine, and artemether. For 
future studies, we have cross-referenced the WHO’s 
essential medicines list with the Wal-Mart $4 drug 
list. This provided a list of drugs that we know will 
be medically necessary and affordable in these areas, 
including acetaminophen, loratadine, ciprofloxacin, 
dexamethasone, metformin, carvedilol, amitriptyline 
and haloperidol.
Drug Name Pump A Pump B Injection Volume Temperature UV Detector




with Diluted  
Phosphoric Acid






Methanol 10 µL 40 °C 210 nm
Ciprofloxacin Acetonitrile Phosphoric Acid 10 µL 29-31 °C 278 nm
Haloperidol Methanol Potassium Phosphate 15 µL 25 °C 254 nm
Hydrochlorothiazide Acetonitrile 0.05M Potassium Phosphate (pH=3.0) 20 µL 37 °C 272 nm




Phosphate (pH=3.0) Acetonitrile 20 µL 25 °C 303 nm
Mefloquine (Mephaquin) 0.05M Potassium Phosphate Methanol 20 µL 30 °C 283 nm
Quinine (Quinine Sulphate 
BP)
0.05M Potassium 
Phosphate (pH=2.0) Acetonitrile 10 µL 30 °C 347 nm
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As an example, acetaminophen tablets were tested 
using the method at both Purdue and at KSP. Purdue 
students tested four tablets obtained from a local 
pharmacy and manufactured in the US. Eight KSP 
students each tested three tablets manufactured in 
Tanzania, China or India. 
 
The Purdue team found an average retention time 
over four experiments of 5.05 minutes +/-0.01. Area 
and area percent of the primary peak is reported  
for each experiment in Table 3. It should be noted 
that Samples 3 and 6 were not properly filtered prior 
to analysis. 
 
The results in Table 3 indicate that the developed 
method tested by Purdue students was repeatable  
and able to verify purity within 99% peak area. 
Results of Studies Performed by Students  
at the Kilimanjaro School of Pharmacy
In March of 2016, in our manufacturing course in 
Purdue’s master’s program at the Kilimanjaro School 
of Pharmacy, a variety of procedures were performed 
to help students better understand the use of HPLC. 
These procedures included typical validation proce-
dures like linearity, precision, and accuracy and tablet 
assaying to compare the quality of different tablets. 
the USP. This proved to us that they would be able to 
be manipulated to analyze many different drugs and, 
therefore, suitable for our universal method.
 
In an effort to make testing as simple as possible, it 
was decided to use four solvents. This is a challenge 
as the chemistry of each drug is different, and they 
each have HPLC procedures previously developed 
to optimize their elution through the instrument 
that may or may not involve the solvents that were 
chosen. All of our methods are based on the four 
solvents: water, methanol, acetonitrile, and 0.5M 
potassium phosphate at varied pH levels using phos-
phoric acid for all pH adjustments. These methods 
are being called our universal methods, and we have 
worked to find the right settings, which will have 
a single peak for each of the initial five common 
SSFFC drugs of interest. 
RESULTS 
Results of Studies Performed by  
Students at Purdue University
Investigations at Purdue University focused on 
determining which combinations of the four solvents 
worked best for the universal method. Table 2 shows 
all drugs tested and the best solvent system associ-
ated with each one.
Sample Number (Date 
Tested) Retention Time (min) Area (mAu*s) Area %
Sample 1 (Jan. 26) 5.050666667 20052.46667 100
Sample 1 (Jan. 27) 5.067333333 16096.4 100
Sample 2 (Feb. 1) 5.042333333 16200.4 99.93713333
Sample 2 (Feb. 3) 5.06 16241.45 100
Sample 3 (Feb. 1) 4.929 104301.5 99.22085
Sample 4 (Feb. 3) 5.0505 16237.15 100
Sample 4 (Feb. 8) 5.096 16221.63333 99.79413333
AUC
Standard No. Replicate 1 Replicate 2 Replicate 3 Average Std. Dev. RSD
1 18604.1 18943.1 19004 18850.4 215.464545 1.14302373
2 9512.9 9504.3 9445.4 9487.53333 36.7410307 0.38725588
3 1848.7 1856.2 1853.8 1852.9 3.8301436 0.20671076
AVERAGE = 0.57899679
Table 3. Retention time studies performed by students at Purdue.
Table 4. Example precision data obtained from the Kilimanjaro School of Pharmacy.
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the preparation of multiple standard solutions. From 
these standard solutions, multiple AUC measure-
ments were made and recorded. From this data, 
the relative standard deviation was measured and 
averaged across the data. An example of this data is 
provided in Table 4.
For the accuracy measurements, the relative 
closeness of the results of the analytical method to 
the true value is measured. This was done through 
the preparation of several concentrations through 
serial dilution. The AUC was then measured and 
used to estimate the concentration with the prepared 
calibration curve. Finally, using the estimated 
concentration, the percent recovery was estimated 
compared to the expected concentration and averaged 
across the data. An example of this data is provided 
in Table 5. 
Finally, a tablet assay was used to illustrate how 
HPLC can be used to compare the content and  
quality of acetaminophen tablets produced in differ-
ent countries. Tablets produced in China, Tanzania, 
and India were studied. The AUC was measured and 
the concentration was estimated using a previously 
prepared calibration curve. Using the known volume 
of the mobile phase used in the preparation of the 
sample solutions, the mass content of the tablets was 
determined from the estimated concentration. An 
example of this data is provided in Table 6. Tablets 
from all three countries were slightly below label but 
still within 90% of the labeled amount.
 
The study involved carrying out a linearity, preci-
sion, and accuracy analysis utilizing a secondary 
reference standard. For linearity, a proportional 
relationship between response and concentration is 
demonstrated for a desired range of concentrations.  
A serial dilution method was used from a stock  
solution of acetaminophen in mobile phase. From  
this serial dilution, the area under the curve (AUC) 
was measured and plotted against the respective 
concentration. These data were used to construct a 
calibration curve, as shown in Figure 4.
For precision, the relative repeatability of the ana-




Concentration (mg/mL) % RECOVERY
0.63 18604.1 0.561023 89.05126984
0.315 9512.9 0.288287 91.51968254
0.126 3544 0.109220 86.68253968
  AVERAGE = 89.08449735
Table 5. Example accuracy data obtained from the Kilimanjaro School of Pharmacy.
Table 6. Example tablet assay data obtained from the Kilimanjaro School of Pharmacy.
Country of Origin AUC Calculated Concentration (mg/mL)
Mass Content of  
Acetaminophen (mg)
China 15093.4 0.455702 455.702
Tanzania 15723.1 0.474593 474.593
India 15196.1 0.458783 458.783
Figure 4. Example calibration curve obtained from the 
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manjaro School of Pharmacy. Since its inception in 
2007, this certificate program serves as a transition 
to a Master of Science in technology, leadership, and 
innovation with a concentration in biotechnology, 
innovation, and regulatory affairs (BIRS) through 
the Purdue Polytechnic Institute and its Center for 
Professional Studies.
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CONCLUSION
The discrepancies in the results between the two 
groups of students highlight a need for clarity. This 
module is most effective when a calibration curve is 
developed and drug concentrations are analyzed for 
percent recovery in addition to observation of the 
retention time and peak area percentage. Retention 
time verifies the correct compound is in the drug 
product, and the percent recovery allows for method 
verification as well as quality metrics. Peak area per-
centage can be used to understand the level of purity 
in the drug. 
 
The results obtained by both the student teams at 
Purdue University and Kilimanjaro School of  
Pharmacy indicate that the concept of a universal 
method is a useful tool for addressing testing of 
SSFFC drugs. The developed method was validated 
and conforms to a broader attempt by students at 
both institutions to create HPLC methods that are 
simple and effective at quantifying the active phar-
maceutical ingredient in an oral formulation.
NOTE
The Sustainable Medicine Program in Tanzania was 
established by Stephen Byrn (Purdue University 
College of Pharmacy), Sister Zita Ekeocha and John 
Chilunda (St. Luke Foundation/Kilimanjaro School 
of Pharmacy), and Joseph Fortunak (Howard Uni-
versity). The program was developed to help combat 
poor quality of medications due to counterfeiting 
and manufacturing issues. The program consists of 
educational programs in pharmaceutical sciences 
and good manufacturing practices (GMP), and a 
GMP pharmaceutical manufacturing facility and 
analytical laboratory at St. Luke Foundation/Kili-
